{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:45:37Z","timestamp":1792266337190,"version":"4.4.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-026-06322-x","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:10:59Z","timestamp":1792213859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Divergent approaches to rheumatoid arthritis\u2013associated interstitial lung disease: a comparative analysis of international clinical practice guidelines"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5928-1092","authenticated-orcid":false,"given":"Rodrigo","family":"Garcia-Salinas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Ch\u00e1vez-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7082-6233","authenticated-orcid":false,"given":"Ramiro A.","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4909-6766","authenticated-orcid":false,"given":"Mar\u00eda","family":"Otaola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Quadrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7802-0317","authenticated-orcid":false,"given":"Pedro","family":"Santos-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4282-4011","authenticated-orcid":false,"given":"Gabriela","family":"Tabaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda Elena","family":"Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2344-2285","authenticated-orcid":false,"given":"Ricardo","family":"Blanco Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,17]]},"reference":[{"key":"6322_CR1","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS (2018) Diagnosis and Management of Rheumatoid Arthritis: A Review. JAMA 320:1360\u20131372. https:\/\/doi.org\/10.1001\/jama.2018.13103","journal-title":"JAMA"},{"key":"6322_CR2","doi-asserted-by":"publisher","first-page":"210011","DOI":"10.1183\/16000617.0011-2021","volume":"30","author":"S Kadura","year":"2021","unstructured":"Kadura S, Raghu G (2021) Rheumatoid arthritis-interstitial lung disease: Manifestations and current concepts in pathogenesis and management. Eur Respir Rev 30:210011. https:\/\/doi.org\/10.1183\/16000617.0011-2021","journal-title":"Eur Respir Rev"},{"key":"6322_CR3","doi-asserted-by":"publisher","first-page":"837133","DOI":"10.3389\/fmed.2022.837133","volume":"9","author":"A Laria","year":"2022","unstructured":"Laria A, Lurati AM, Zizzo G et al (2022) Interstitial Lung Disease in Rheumatoid Arthritis: A Practical Review. Front Med (Lausanne) 9:837133. https:\/\/doi.org\/10.3389\/fmed.2022.837133","journal-title":"Front Med (Lausanne)"},{"key":"6322_CR4","doi-asserted-by":"publisher","first-page":"2332406","DOI":"10.1080\/07853890.2024.2332406","volume":"56","author":"HF Wang","year":"2024","unstructured":"Wang HF, Wang YY, Li ZY et al (2024) The prevalence and risk factors of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis. Ann Med 56:2332406. https:\/\/doi.org\/10.1080\/07853890.2024.2332406","journal-title":"Ann Med"},{"key":"6322_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","volume":"168","author":"BR Gochuico","year":"2008","unstructured":"Gochuico BR, Avila NA, Chow CK et al (2008) Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med 168:159\u2013166. https:\/\/doi.org\/10.1001\/archinternmed.2007.59","journal-title":"Arch Intern Med"},{"key":"6322_CR6","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1183\/09031936.00092309","volume":"35","author":"EJ Kim","year":"2010","unstructured":"Kim EJ, Elicker BM, Maldonado F et al (2010) Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 35:1322\u20131328. https:\/\/doi.org\/10.1183\/09031936.00092309","journal-title":"Eur Respir J"},{"key":"6322_CR7","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/rheumatology\/kew391","volume":"56","author":"JA Zamora-Legoff","year":"2017","unstructured":"Zamora-Legoff JA, Krause ML, Crowson CS et al (2017) Patterns of interstitial lung disease and mortality in rheumatoid arthritis. Rheumatol (United Kingdom) 56:344\u2013350. https:\/\/doi.org\/10.1093\/rheumatology\/kew391","journal-title":"Rheumatol (United Kingdom)"},{"key":"6322_CR8","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1183\/13993003.00357-2015","volume":"47","author":"JJ Solomon","year":"2016","unstructured":"Solomon JJ, Chung JH, Cosgrove GP et al (2016) Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 47:588\u2013596. https:\/\/doi.org\/10.1183\/13993003.00357-2015","journal-title":"Eur Respir J"},{"key":"6322_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1055\/s-0044-1782218","volume":"45","author":"JV Pugashetti","year":"2024","unstructured":"Pugashetti JV, Lee JS (2024) Overview of Rheumatoid Arthritis-Associated Interstitial Lung Disease and Its Treatment. Semin Respir Crit Care Med 45:329\u2013341. https:\/\/doi.org\/10.1055\/s-0044-1782218","journal-title":"Semin Respir Crit Care Med"},{"key":"6322_CR10","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/acr.25348","volume":"76","author":"SR Johnson","year":"2024","unstructured":"Johnson SR, Bernstein EJ, Bolster MB et al (2024) 2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Care Res (Hoboken) 76:1051\u20131069. https:\/\/doi.org\/10.1002\/acr.25348","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6322_CR11","doi-asserted-by":"publisher","unstructured":"Alberti ML, Auteri SJ, Rojas-Serrano J et al (2026) Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD): An Official 2025 ALAT Clinical Practice Guideline. https:\/\/doi.org\/10.1016\/j.arbres.2026.04.001. Arch Bronconeumol","DOI":"10.1016\/j.arbres.2026.04.001"},{"key":"6322_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ard.2025.08.021","volume":"85","author":"KM Antoniou","year":"2026","unstructured":"Antoniou KM, Distler O, Gheorghiu AM et al (2026) ERS\/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease developed by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR) Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG). Ann Rheum Dis 85:22\u201360. https:\/\/doi.org\/10.1016\/j.ard.2025.08.021","journal-title":"Ann Rheum Dis"},{"key":"6322_CR13","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/art.42860","volume":"76","author":"SR Johnson","year":"2024","unstructured":"Johnson SR, Bernstein EJ, Bolster MB et al (2024) 2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Rheumatol 76:1201\u20131213. https:\/\/doi.org\/10.1002\/art.42860","journal-title":"Arthritis Rheumatol"},{"key":"6322_CR14","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.ard.2026.01.023","volume":"85","author":"JS Smolen","year":"2026","unstructured":"Smolen JS, Edwards CJ, Konzett V et al (2026) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update. Ann Rheum Dis 85:991\u20131009. https:\/\/doi.org\/10.1016\/j.ard.2026.01.023","journal-title":"Ann Rheum Dis"},{"key":"6322_CR15","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1016\/S2665-9913(25)00259-0","volume":"8","author":"P Santos Moreno","year":"2026","unstructured":"Santos Moreno P, Garc\u00eda Salinas R, Caballero Uribe CV et al (2026) Pan American League of Associations for Rheumatology recommendations for the management of rheumatoid arthritis. Lancet Rheumatol 8:e53\u2013e65. https:\/\/doi.org\/10.1016\/S2665-9913(25)00259-0","journal-title":"Lancet Rheumatol"},{"key":"6322_CR16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.reumae.2022.02.004","volume":"18","author":"JA Rodr\u00edguez Portal","year":"2022","unstructured":"Rodr\u00edguez Portal JA, Brito Garc\u00eda N, del D\u00edaz P et al (2022) SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis. Reumatolog\u00eda Cl\u00ednica (English Edition) 18:443\u2013452. https:\/\/doi.org\/10.1016\/j.reumae.2022.02.004","journal-title":"Reumatolog\u00eda Cl\u00ednica (English Edition)"},{"key":"6322_CR17","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.reumae.2022.03.004","volume":"18","author":"J Narv\u00e1ez","year":"2022","unstructured":"Narv\u00e1ez J, D\u00edaz del Campo Fontecha P, Brito Garc\u00eda N et al (2022) SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment. Reumatolog\u00eda Cl\u00ednica. (English Edition) 18:501\u2013512. https:\/\/doi.org\/10.1016\/j.reumae.2022.03.004","journal-title":"(English Edition)"},{"key":"6322_CR18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA et al (2011) GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64:383\u2013394. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.026","journal-title":"J Clin Epidemiol"},{"key":"6322_CR19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Kunz R et al (2011) GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 64:395\u2013400. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.09.012","journal-title":"J Clin Epidemiol"},{"key":"6322_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1472-6947-7-16","volume":"7","author":"C Schardt","year":"2007","unstructured":"Schardt C, Adams MB, Owens T et al (2007) Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inf Decis Mak 7:16. https:\/\/doi.org\/10.1186\/1472-6947-7-16","journal-title":"BMC Med Inf Decis Mak"},{"key":"6322_CR21","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L et al (2022) Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med 205:e18\u2013e47. https:\/\/doi.org\/10.1164\/rccm.202202-0399ST","journal-title":"Am J Respir Crit Care Med"},{"key":"6322_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S2213-2600(20)30036-9","volume":"8","author":"AU Wells","year":"2020","unstructured":"Wells AU, Flaherty KR, Brown KK et al (2020) Nintedanib in patients with progressive fibrosing interstitial lung diseases\u2014subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Respir Med 8:453\u2013460. https:\/\/doi.org\/10.1016\/S2213-2600(20)30036-9","journal-title":"Lancet Respir Med"},{"key":"6322_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","volume":"75","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Breedveld FC, Burmester GR et al (2016) Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 75:3\u201315. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207524","journal-title":"Ann Rheum Dis"},{"key":"6322_CR24","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1093\/rheumatology\/key208","volume":"58","author":"CR Holroyd","year":"2019","unstructured":"Holroyd CR, Seth R, Bukhari M et al (2019) The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis. Rheumatology (Oxford) 58:e3\u2013e42. https:\/\/doi.org\/10.1093\/rheumatology\/key208","journal-title":"Rheumatology (Oxford)"},{"key":"6322_CR25","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1093\/rheumatology\/keaa621","volume":"59","author":"C Fern\u00e1ndez-D\u00edaz","year":"2020","unstructured":"Fern\u00e1ndez-D\u00edaz C, Casta\u00f1eda S, Melero-Gonz\u00e1lez RB et al (2020) Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients. Rheumatol (United Kingdom) 59:3906\u20133916. https:\/\/doi.org\/10.1093\/rheumatology\/keaa621","journal-title":"Rheumatol (United Kingdom)"},{"key":"6322_CR26","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1093\/rheumatology\/kex072","volume":"56","author":"MY Md Yusof","year":"2017","unstructured":"Md Yusof MY, Kabia A, Darby M et al (2017) Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10 years\u2019 experience at a single centre. Rheumatol (United Kingdom) 56:1348\u20131357. https:\/\/doi.org\/10.1093\/rheumatology\/kex072","journal-title":"Rheumatol (United Kingdom)"},{"key":"6322_CR27","doi-asserted-by":"publisher","first-page":"2000337","DOI":"10.1183\/13993003.00337-2020","volume":"57","author":"PA Juge","year":"2021","unstructured":"Juge PA, Lee JS, Lau J et al (2021) Methotrexate and rheumatoid arthritis associated interstitial lung disease. Eur Respir J 57:2000337. https:\/\/doi.org\/10.1183\/13993003.00337-2020","journal-title":"Eur Respir J"},{"key":"6322_CR28","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.reumae.2021.07.002","volume":"18","author":"S Garrote-Corral","year":"2022","unstructured":"Garrote-Corral S, Silva-Fern\u00e1ndez L, Seoane-Mato D et al (2022) Screening of interstitial lung disease in patients with rheumatoid arthritis: A systematic review. Reumatolog\u00eda Cl\u00ednica (English Edition) 18:587\u2013596. https:\/\/doi.org\/10.1016\/j.reumae.2021.07.002","journal-title":"Reumatolog\u00eda Cl\u00ednica (English Edition)"},{"key":"6322_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s42358-021-00209-0","volume":"61","author":"F Paulin","year":"2021","unstructured":"Paulin F, Secco A, Benavidez F et al (2021) Lung involvement prevalence in patients with early rheumatoid arthritis without known pulmonary disease: a multicentric cross sectional study. Adv Rheumatol 61:52. https:\/\/doi.org\/10.1186\/s42358-021-00209-0","journal-title":"Adv Rheumatol"},{"key":"6322_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12931-025-03416-1","volume":"26","author":"C Yao","year":"2025","unstructured":"Yao C, Lu Y, Dou D et al (2025) Rheumatoid arthritis-associated interstitial lung disease: clinical predictive model and external validation. Respir Res 26:331. https:\/\/doi.org\/10.1186\/s12931-025-03416-1","journal-title":"Respir Res"},{"key":"6322_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00296-025-05789-4","volume":"45","author":"H Prasanna","year":"2025","unstructured":"Prasanna H, Inderjeeth CA, Nossent JC, Almutairi KB (2025) The global prevalence of interstitial lung disease in patients with rheumatoid arthritis: a systematic review and meta-analysis. Rheumatol Int 45:34. https:\/\/doi.org\/10.1007\/s00296-025-05789-4","journal-title":"Rheumatol Int"},{"key":"6322_CR32","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s00296-025-06005-z","volume":"45","author":"E Blomberg","year":"2025","unstructured":"Blomberg E, Wahlin B, S\u00f6dergren A (2025) Comparable area under the curve for three risk scores to detect interstitial lung disease in patients with rheumatoid arthritis: an external validation. Rheumatol Int 45:252. https:\/\/doi.org\/10.1007\/s00296-025-06005-z","journal-title":"Rheumatol Int"},{"key":"6322_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00296-026-06268-0","volume":"46","author":"A Lewandowska-Polak","year":"2026","unstructured":"Lewandowska-Polak A, Brzezi\u0144ska O, Krawiec P et al (2026) Diagnostic methods of rheumatoid arthritis-associated interstitial lung disease: a systematic review. Rheumatol Int 46:229. https:\/\/doi.org\/10.1007\/s00296-026-06268-0","journal-title":"Rheumatol Int"},{"key":"6322_CR34","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1007\/s10067-025-07510-z","volume":"44","author":"EE Schneeberger","year":"2025","unstructured":"Schneeberger EE, Perandones M, Rosemffet MG et al (2025) Clinical variables and lung ultrasonography for the screening of interstitial lung disease in patients with rheumatoid arthritis. Clin Rheumatol 44:3167\u20133175. https:\/\/doi.org\/10.1007\/s10067-025-07510-z","journal-title":"Clin Rheumatol"},{"key":"6322_CR35","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.chest.2024.11.038","volume":"167","author":"M Otaola","year":"2025","unstructured":"Otaola M, Vasarmidi E, Ottaviani S et al (2025) Performance of Lung Ultrasound as a Screening Tool for Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease. Chest 167:1687\u20131695. https:\/\/doi.org\/10.1016\/j.chest.2024.11.038","journal-title":"Chest"},{"key":"6322_CR36","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/MCP.0000000000001200","volume":"31","author":"M Otaola","year":"2025","unstructured":"Otaola M, Davidsen JR (2025) Lung ultrasound as a screening tool for interstitial lung disease in patients with rheumatoid arthritis: state of the art. Curr Opin Pulm Med 31:476\u2013483. https:\/\/doi.org\/10.1097\/MCP.0000000000001200","journal-title":"Curr Opin Pulm Med"},{"key":"6322_CR37","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.3390\/jcm14113701","volume":"14","author":"EF Vicente-Rabaneda","year":"2025","unstructured":"Vicente-Rabaneda EF, M\u00f6ller I, Mata A et al (2025) A Proposal for a New Lung Ultrasound Score in Rheumatoid Arthritis: The Reliability of Lung Ultrasound for Rheumatoid Arthritis-Associated Interstitial Lung Disease Diagnosis. J Clin Med 14:3701. https:\/\/doi.org\/10.3390\/jcm14113701","journal-title":"J Clin Med"},{"key":"6322_CR38","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1080\/17476348.2024.2374910","volume":"18","author":"Y Kondoh","year":"2024","unstructured":"Kondoh Y, Bando M, Kawahito Y et al (2024) Identification and management of interstitial lung disease associated with systemic sclerosis (SSc-ILD), rheumatoid arthritis (RA-ILD), and polymyositis\/dermatomyositis (PM\/DM-ILD): development of expert consensus-based clinical algorithms. Expert Rev Respir Med 18:447\u2013456. https:\/\/doi.org\/10.1080\/17476348.2024.2374910","journal-title":"Expert Rev Respir Med"},{"key":"6322_CR39","doi-asserted-by":"publisher","first-page":"105790","DOI":"10.1016\/j.jbspin.2024.105790","volume":"91","author":"B Fautrel","year":"2024","unstructured":"Fautrel B, Kedra J, Rempenault C et al (2024) 2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis. Joint Bone Spine 91:105790. https:\/\/doi.org\/10.1016\/j.jbspin.2024.105790","journal-title":"Joint Bone Spine"},{"key":"6322_CR40","doi-asserted-by":"crossref","unstructured":"Sociedad Argentina de Reumatolog\u00eda (2025) Recomendaciones de la Sociedad Argentina de Reumatolog\u00eda para el tratamiento de la artritis reumatoidea [special issue]. Rev Argent Reumatol 36(Suppl 1). https:\/\/ojs.reumatologia.org.ar\/index.php\/revistaSAR\/issue\/view\/80","DOI":"10.47196\/rar.v36i1.914"},{"key":"6322_CR41","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/14737167.2023.2207825","volume":"23","author":"D Rosselli","year":"2023","unstructured":"Rosselli D (2023) High cost drugs in Latin America: access and barriers. Expert Rev Pharmacoecon Outcomes Res 23:619\u2013623. https:\/\/doi.org\/10.1080\/14737167.2023.2207825","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"6322_CR42","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1007\/s10067-020-05555-w","volume":"40","author":"DG Fern\u00e1ndez-\u00c1vila","year":"2021","unstructured":"Fern\u00e1ndez-\u00c1vila DG, Patino-Hernandez D, Kowalskii S et al (2021) Current status of the rheumatologists\u2019 workforce in Latin America: a PANLAR collaborative study. Clin Rheumatol 40:2913\u20132920. https:\/\/doi.org\/10.1007\/s10067-020-05555-w","journal-title":"Clin Rheumatol"},{"key":"6322_CR43","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S2213-2600(26)00094-9","volume":"14","author":"JJ Solomon","year":"2026","unstructured":"Solomon JJ, Dieud\u00e9 P, Matson SM et al (2026) Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment\u2014an expert group consensus statement. Lancet Respir Med 14:820\u2013836. https:\/\/doi.org\/10.1016\/S2213-2600(26)00094-9","journal-title":"Lancet Respir Med"},{"key":"6322_CR44","doi-asserted-by":"publisher","first-page":"152973","DOI":"10.1016\/j.semarthrit.2026.152973","volume":"78","author":"GC McDermott","year":"2026","unstructured":"McDermott GC, Solomon DH, Sparks JA, Desai RJ (2026) Target trial emulation of biologic and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis-associated interstitial lung disease. Semin Arthritis Rheum 78:152973. https:\/\/doi.org\/10.1016\/j.semarthrit.2026.152973","journal-title":"Semin Arthritis Rheum"},{"key":"6322_CR45","doi-asserted-by":"publisher","first-page":"152881","DOI":"10.1016\/j.semarthrit.2025.152881","volume":"75","author":"R Garcia-Salinas","year":"2025","unstructured":"Garcia-Salinas R, Mej\u00eda-Maggi N, Almada F et al (2025) Progression from seropositive arthralgia to rheumatoid arthritis: One-year predictors from a large cohort in the Reuma-Check program. Semin Arthritis Rheum 75:152881. https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152881","journal-title":"Semin Arthritis Rheum"},{"key":"6322_CR46","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s10067-019-04855-0","volume":"39","author":"S Ruta","year":"2020","unstructured":"Ruta S, Prado ES, Chichande JT et al (2020) EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis in a large cohort of patients included in a program for rapid diagnosis: role of auto-antibodies and ultrasound. Clin Rheumatol 39:1493\u20131499. https:\/\/doi.org\/10.1007\/s10067-019-04855-0","journal-title":"Clin Rheumatol"},{"key":"6322_CR47","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3899\/jrheum.2025-0797","volume":"53","author":"LA O\u2019Keeffe","year":"2026","unstructured":"O\u2019Keeffe LA, Getachew LS, Nety SP et al (2026) Screening for rheumatoid arthritis-associated interstitial lung disease: Current evidence and next steps needed for routine clinical use. J Rheumatol 53:362\u2013375. https:\/\/doi.org\/10.3899\/jrheum.2025-0797","journal-title":"J Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06322-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-026-06322-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06322-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:04:00Z","timestamp":1792263840000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-026-06322-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,17]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["6322"],"URL":"https:\/\/doi.org\/10.1007\/s00296-026-06322-x","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,17]]},"assertion":[{"value":"24 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RGS has received speaker fees from AbbVie, Novartis, Janssen, Pfizer, Lilly, and Sandoz, and consulting fees from AbbVie and Janssen. RGS is an author of the PANLAR recommendations for the management of rheumatoid arthritis and of the ALAT guideline on RA-ILD, both analyzed in this manuscript. PSM has received research support from Pfizer, Novartis, and Bristol Myers Squibb; speaker fees from Novartis, Amgen, and Janssen; and has participated in advisory boards for Bristol Myers Squibb, Amgen, Biopas, and UCB. PSM is an author of the PANLAR recommendations analyzed in this manuscript. SQ, MO, BV, and GT have received speaker fees and\/or participated in advisory activities for Adium, Boehringer Ingelheim, Bag\u00f3, and Tuteur. MO has participated in clinical research for Boehringer Ingelheim, Bristol Myers Squibb, Sanofi, and United Therapeutics. GT has participated in clinical research for Boehringer Ingelheim, Bristol Myers Squibb, Vicore, Sanofi, and United Therapeutics, and in advisory boards for Boehringer Ingelheim, Bristol Myers Squibb, Knight, and Adium. BV has also received speaker fees and\/or participated in advisory activities for Finadiet and Roche. The remaining authors declare no conflicts of interest or have disclosures to be confirmed.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ChatGPT (OpenAI) was used from May to September 2026 to assist with language editing, manuscript structure, wording of responses to reviewers, and reference formatting. Codex based on GPT-6 was used during the September 2026 revision. All AI-assisted suggestions incorporated into the manuscript were reviewed and revised by the authors. The authors verified the scientific statements and bibliographic references, approved the final text, and take full responsibility for its accuracy, integrity, and originality.","order":2,"name":"Ethics","label":"Declaration of AI-assisted editing","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This review is an original work, has not been published previously, and is not under consideration elsewhere. No text has been copied from other publications without appropriate quotation or attribution. AI-assisted tools were disclosed above; the authors reviewed and revised any AI-assisted wording and are responsible for all analyses, interpretations, conclusions, and final text.","order":3,"name":"Ethics","label":"Disclaimer","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"291"}}